Sanara MedTech (SMTI) Asset Writedowns and Impairment (2010 - 2026)
Sanara MedTech's (SMTI) quarterly Asset Writedowns and Impairment came in at $62800.0 in Q1 2026, down 68.49% YoY from $199278.0 in Q1 2025, and up 101.98% on a QoQ basis from -$3.2 million in Q4 2025.
Sanara MedTech (SMTI) Asset Writedowns and Impairment (2010 - 2026) Analysis & Trends
Sanara MedTech (SMTI) has 15 years of Asset Writedowns and Impairment data on file, last reported at $62800.0 in Q1 2026.
- Quarterly Asset Writedowns and Impairment fell 68.49% year-over-year to $62800.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.9 million (down 468.71% YoY) and the FY2025 annual result came in at $1.2 million, up 92.17% from the prior year.
- Asset Writedowns and Impairment climbed to $62800.0 in Q1 2026, from -$3.2 million in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $393518.0 in Q4 2024 to a low of -$3.2 million in Q4 2025.
- A 5-year average of -$67834.2 and a median of $96684.0 in 2024 frame the typical range for Asset Writedowns and Impairment.
- Annual changes were most pronounced in 2022 — Asset Writedowns and Impairment jumped 24490.24% — and 2025, when it tumbled 906.28%.
- Tracing SMTI's Asset Writedowns and Impairment over 5 years: stood at $250684.0 in 2022, then tumbled by 48.58% to $128911.0 in 2023, then soared by 205.26% to $393518.0 in 2024, then plunged by 906.28% to -$3.2 million in 2025, then soared by 101.98% to $62800.0 in 2026.
- The last three Asset Writedowns and Impairment figures came in at $62800.0 (Q1 2026), -$3.2 million (Q4 2025), and $117615.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Sanara MedTech | 297.82 Mn | 297.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 62,800.00 |
| Mar 31, 2026 | 62,800.00 |
| Dec 31, 2025 | -3.17 Mn |
| Dec 31, 2025 | -3.17 Mn |
| Sep 30, 2025 | 117,615.00 |
| Sep 30, 2025 | 117,615.00 |
| Jun 30, 2025 | 115,000.00 |
| Jun 30, 2025 | 115,000.00 |
| Mar 31, 2025 | 199,278.00 |
| Mar 31, 2025 | 199,278.00 |
| Dec 31, 2024 | 393,518.00 |
| Dec 31, 2024 | 393,518.00 |
| Sep 30, 2024 | 96,684.00 |
| Sep 30, 2024 | 96,684.00 |
| Jun 30, 2024 | 90,930.00 |
| Jun 30, 2024 | 90,930.00 |
| Mar 31, 2024 | 65,000.00 |
| Mar 31, 2024 | 65,000.00 |
| Dec 31, 2023 | 128,911.00 |
| Dec 31, 2023 | 128,911.00 |